Mirae Asset Global Investments Co., Ltd. Entrada Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,466 shares of TRDA stock, worth $9,059. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,466
Previous 1,258
16.53%
Holding current value
$9,059
Previous $11,000
18.18%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding TRDA
# of Institutions
107Shares Held
28.8MCall Options Held
15.7KPut Options Held
0-
Baker Bros. Advisors LP New York, NY4.87MShares$30.1 Million0.33% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.38MShares$27.1 Million67.92% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.31MShares$26.6 Million19.43% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.57MShares$15.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$10.5 Million0.0% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $194M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...